Screener
D&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Surgery Partners, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Surgery Partners, Inc.’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001638833-26-000077
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other operating expenses | 51.8 | 55.4 | 110.6 | 99.0 |
| Cost of revenues | 658.7 | 630.6 | 1,309.4 | 1,244.7 |
| General and administrative expenses | 36.3 | 36.1 | 75.6 | 72.1 |
| Depreciation and amortization | 39.3 | 40.3 | 77.8 | 76.6 |
| Transaction and integration costs | 18.4 | 18.1 | 34.0 | 42.8 |
| Net (gain) loss on disposals, consolidations and deconsolidations | 2.4 | (3.0) | 6.7 | 3.4 |
| Equity in earnings of unconsolidated affiliates | (6.4) | (5.5) | (10.5) | (11.1) |
| Litigation settlements | — | — | 2.5 | 2.2 |
Item 1. Financial Statements
FAQ
- What is Surgery Partners, Inc.'s D&A?
- Surgery Partners, Inc. (SGRY) reported D&A of $39.3M in Q2 2026.
- How has Surgery Partners, Inc.'s D&A changed year-over-year?
- Surgery Partners, Inc.'s D&A decreased by 2.5% year-over-year, from $40.3M to $39.3M.
- What is the long-term trend for Surgery Partners, Inc.'s D&A?
- Over 4 years (2021 to 2025), Surgery Partners, Inc.'s D&A has grown at a 15.5% compound annual growth rate (CAGR), from $98.8M to $176M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Surgery Partners, Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude